1. Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer
   Hisao Imai et al, 2022, Investigational New Drugs CrossRef
2. Relevance of Platinum Sensitivity in Patients with Relapsed or Refractory Small-Cell Lung Cancer
   Young Hak Kim et al, 2015, Journal of Thoracic Oncology CrossRef
3. A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients
   null null et al, 2017, Cancer Chemotherapy and Pharmacology CrossRef